Total Payments
$1,174
2022 Payments
$11.71
Companies
17
Transactions
88
Medicare Patients
3,520
Medicare Billing
$207,642
Payment Breakdown by Category
Food & Beverage$1,162 (99.0%)
Education$11.71 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,162 | 87 | 99.0% |
| Education | $11.71 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $371.90 | 28 | $0 (2018) |
| Amarin Pharma Inc. | $184.99 | 14 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $108.43 | 8 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $101.04 | 8 | $0 (2018) |
| GlaxoSmithKline, LLC. | $82.59 | 5 | $0 (2018) |
| PFIZER INC. | $80.03 | 7 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $73.27 | 5 | $0 (2018) |
| Sanofi Pasteur Inc. | $38.70 | 3 | $0 (2018) |
| Amgen Inc. | $29.31 | 2 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $16.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2019 | $12.86 | 1 | Amarin Pharma Inc. ($12.86) |
| 2018 | $461.66 | 36 | Novo Nordisk Inc ($124.01) |
| 2017 | $687.48 | 50 | Novo Nordisk Inc ($247.89) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA, INVOKAMET | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/26/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 03/19/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: Diabetes | ||||||
| 02/21/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/09/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/07/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $12.26 | General |
| Category: Cardiovascular | ||||||
| 01/31/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/24/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: VACCINE | ||||||
| 01/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/10/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: Diabetes | ||||||
| 01/08/2018 | GlaxoSmithKline, LLC. | ANORO (Drug), LEVITRA | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: RESPIRATORY | ||||||
| 01/05/2018 | GlaxoSmithKline, LLC. | ANORO (Drug), LEVITRA | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: RESPIRATORY | ||||||
| 12/22/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/18/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/29/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: Cardiovascular | ||||||
| 11/27/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 11/06/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/28/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $9.75 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/24/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/23/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Obesity | ||||||
| 10/06/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 760 | 1,032 | $201,339 | $43,484 |
| 2022 | 13 | 727 | 958 | $198,406 | $43,423 |
| 2021 | 13 | 915 | 1,153 | $202,800 | $54,315 |
| 2020 | 16 | 1,118 | 1,314 | $203,022 | $66,421 |
Total Patients
3,520
Total Services
4,457
Medicare Billing
$207,642
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 241 | 356 | $71,200 | $15,613 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 156 | 277 | $77,837 | $13,359 | 17.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 67 | 67 | $9,648 | $5,079 | 52.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 75 | $5,625 | $2,465 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $18,720 | $2,056 | 11.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $3,204 | $1,570 | 49.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 65 | 65 | $2,730 | $1,259 | 46.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 15 | $9,195 | $646.20 | 7.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 11 | $782.00 | $516.16 | 66.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $1,125 | $493.05 | 43.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 29 | $928.00 | $339.64 | 36.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 15 | 16 | $112.00 | $54.56 | 48.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 29 | $233.36 | $33.55 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 224 | 346 | $69,546 | $15,843 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 262 | $74,408 | $13,060 | 17.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 61 | 64 | $7,808 | $4,367 | 55.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 66 | $4,950 | $2,149 | 43.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $17,400 | $2,092 | 12.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $2,640 | $1,449 | 54.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 17 | 17 | $10,421 | $1,339 | 12.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 15 | $6,795 | $1,152 | 17.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 58 | 58 | $2,436 | $1,150 | 47.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $975.00 | $425.34 | 43.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 14 | $462.00 | $162.82 | 35.2% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $418.00 | $161.04 | 38.5% |
About Dr. Toby Tracy, DO
Dr. Toby Tracy, DO is a Family Medicine healthcare provider based in Little Egg Harbor, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316029689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Toby Tracy, DO has received a total of $1,174 in payments from pharmaceutical and medical device companies, with $11.71 received in 2022. These payments were reported across 88 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,162).
As a Medicare-enrolled provider, Tracy has provided services to 3,520 Medicare beneficiaries, totaling 4,457 services with total Medicare billing of $207,642. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Little Egg Harbor, NJ
- Active Since 10/19/2006
- Last Updated 01/02/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1316029689
Products in Payments
- Vascepa (Drug) $184.99
- Victoza (Drug) $131.77
- Saxenda (Drug) $87.43
- ANORO (Drug) $82.59
- Tresiba (Drug) $73.51
- Livalo (Drug) $73.27
- JANUVIA (Drug) $55.20
- BEVESPI AEROSPHERE (Drug) $52.73
- FARXIGA (Drug) $48.31
- Ozempic (Drug) $37.35
- PREVNAR - 13 (Biological) $32.68
- Prolia (Biological) $29.31
- Levemir (Drug) $29.10
- ZOSTAVAX (Biological) $27.40
- FLUZONE HIGH-DOSE (Drug) $26.31
- PNEUMOVAX 23 (Biological) $25.83
- CHANTIX (Drug) $25.68
- ELIQUIS (Drug) $21.62
- WATCHMAN (Device) $16.67
- SUBOXONE SUBLINGUAL FILM (Drug) $15.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.